Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Votre recherche
Pays: France,Italy,United Kingdom,Serbia,Germany,Philippines,Bulgaria,Czech Republic,Portugal - Le promoteur: Martin Kropff, MD
Martin Kropff, MD
MAJ Il y a 5 ans
Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma
The primary objective is to compare the time to progression (TTP) of three daily doses of thalidomide (100, 200 and 400 mg) with high-dose dexamethasone in relapsed refractory multiple myeloma (MM) patients and to subsequently select the optimum thalidomide dose in terms of median TPP and toxicity.
Pays
Bulgaria
,
Croatia
,
Czech Republic
,
France
,
Germany
,
Hungary
,
India
,
Italy
,
Philippines
,
Poland
,
Portugal
,
Serbia
,
Slovakia
,
South Africa
,
United Kingdom
,
Organes
Aucun
Spécialités
Aucun
Essai clos aux inclusions
Plus d'informations
1